A Collection of Articles


35 Innovators Under 35


In breaking with the old ways, they create better AI, antibiotics, and even architecture.

Photograph of Nicole Gaudelli

Nicole Gaudelli

Beam Therapeutics
Country of birth: US

She found a better way to correct single-gene mutations

  • by Karen Weintraub
  • Nicole Gaudelli invented a way to potentially correct almost half of all genetic diseases caused by single-gene mutations.

    Gene-editing tools such as CRISPR can fix some of the single-letter genetic “spelling” mistakes that can drive inherited diseases. But they don’t correct for having the nucleic acid adenine, or A, appear in a DNA strand where there should have been a guanine, or G. This misplaced A is involved in sickle cell disease, cystic fibrosis, Parkinson’s, Alzheimer’s, and many types of cancer.

    So Gaudelli set out to make a new enzyme that can cleanly convert A-T base pairs into G-C base pairs with few undesired effects.

    “It was a little bit of magic,” says Gaudelli, about getting her enzyme to work. She’s now a senior scientist at Beam Therapeutics, a biotech company based in Cambridge, Massachusetts, working to commercialize her approach.